Shobhana Subramanian &Amp; Amriteshwar Mathur In Mumbai

Stories by Shobhana Subramanian &Amp; Amriteshwar Mathur In Mumbai

The Dabur strategy: will it work?

The Dabur strategy: will it work?

Rediff.com   6 Feb 2007

Dabur India's brand proliferation contrasts starkly with other FMCG companies' power brands. How effective will the strategy be?

How NSE can be bigger than NYSE

How NSE can be bigger than NYSE

Rediff.com   22 Jan 2007

which currently does an average daily turnover of Rs 8,000 crore (Rs 80 billion) - almost twice that of the Bombay Stock Exchange - has been valued at $2.5 billion.

Tune in to the news

Tune in to the news

Rediff.com   15 Jan 2007

Backed by a good team and riding a buoyant economy, CNN-IBN is a strong contender for the number one slot in the English news genre.

For LIC, life begins at fifty

For LIC, life begins at fifty

Rediff.com   15 Jan 2007

By refocussing on equity-linked products, LIC has managed to turn in some splendid numbers.

Organised retailing set to come of age

Organised retailing set to come of age

Rediff.com   2 Jan 2007

The New Year could well end up being the year of organised retailers.

How Zee scripted its own success story

How Zee scripted its own success story

Rediff.com   26 Dec 2006

The channel invested in formal research into viewing habits and preferences

Bajaj Auto: Discovering the Platina

Bajaj Auto: Discovering the Platina

Rediff.com   24 Dec 2006

Rajiv Bajaj is on a high. First Bajaj Auto raced into the executive segment with the Discover snapping up a share of 21 per cent

India Inc sweetens offers for buys abroad

India Inc sweetens offers for buys abroad

Rediff.com   18 Dec 2006

When textile-maker Alok Textiles bought into $22 million Mileta, it left a good 40 per cent share with the existing shareholders, promising them a better valuation if Mileta turned in a good show.

Indian drug firms top FDA list

Indian drug firms top FDA list

Rediff.com   17 Nov 2006

With 62 filings, domestic pharma companies have filed the maximum number of drug master filings with the US Food and Drug Administration in the July-September 2006 quarter.

The FMCG story: Good times are here

The FMCG story: Good times are here

Rediff.com   13 Nov 2006

He dreams to dress the rest of the world

He dreams to dress the rest of the world

Rediff.com   7 Nov 2006

Tata's global gambit

Tata's global gambit

Rediff.com   6 Nov 2006

Petrol sale margins recover

Petrol sale margins recover

Rediff.com   15 Sep 2006

Why hypermarts are a hit in India

Why hypermarts are a hit in India

Rediff.com   15 Sep 2006

Titan to keep time with Hugo Boss watches

Titan to keep time with Hugo Boss watches

Rediff.com   11 Sep 2006

Siva alters Barista strategy

Siva alters Barista strategy

Rediff.com   31 Aug 2006

Indian drug firms file most DMFs in US

Indian drug firms file most DMFs in US

Rediff.com   21 Aug 2006

Why India Inc is on a M&A spree

Why India Inc is on a M&A spree

Rediff.com   14 Aug 2006

Tatas on a hot acquisition trail

Tatas on a hot acquisition trail

Rediff.com   30 Jun 2006